OBD — Oxford Biodynamics Share News
0.000.00%
- £14.79m
- £16.55m
- £1.10m
RCS - Oxford BioDynamics - OBD in New Report on NHS Prostate Cancer Screening
Brief: Oxford Biodynamics And UEA Develop Test For Chronic Fatigue
Oxford BioDynamics - Holding(s) in Company
RCS - Oxford BioDynamics - Study confirms clinical utility of EpiSwitch CiRT
Brief: Oxford BioDynamics Announces Collaboration With Google Cloud
Oxford BioDynamics - Holding(s) in Company
RCS - Oxford BioDynamics - GenomeWeb to host joint Agilent/OBD presentation
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
RCS - Oxford BioDynamics - Pfizer study on EpiSwitch biomarkers
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Interim Results
Oxford BioDynamics - Holding(s) in Company
RCS - Oxford BioDynamics - OBD’s Oxford Lab accredited by UKAS
Oxford BioDynamics - Director/PDMR Shareholding
Oxford BioDynamics - PDMR Dealing
Oxford BioDynamics - Board Changes
Oxford BioDynamics - Holding(s) in Company
Brief: Oxford Biodynamics Announces Expansion Of OBD/BUPA UK Insurance Partnership